In the very same study that concludes rapid Ag tests do not work in asymptomatic people, the authors failed to state the rapid Ag tests SUCCESSFULLY CAUGHT 100% of ASYMPTOMATIC PEOPLE who had likely contagious virus.
3/x
In this thread I'll try to place that study in context, as well as discuss another highly publicized study from Liverpool,UK which I believe is hitting up against similar issues-in a less explicit way-causing an unnecessary loss in confidence in a rapid Test.
4/x
The @CDCMMWR study linked above failed to define why they were testing and thus got confused.
They said the tests missed 60% of the asymptomatics when in fact they caught 100% of the asymptomatic PCR +ves that they intended to detect!
The culture positive ones!
13/30
***I implore anyone studying rapid Ag tests to first DEFINE WHY YOU'RE TESTING, and from that, choose the metrics that make sense.
This is crucial.
If your unsure what your goals are, don't do the study or find someone to help. I'll help....
14/30
There've been many many rapid Ag test studies by ppl who haven't defined their goal. These unsurprisingly tend to ultimately come to a conlclusion that Rapid Ag tests don't work.
15/30
Meanwhile, studies by experts in this field have largely concluded these tests work well
The study that instigated this thread shows how WELL these tests work- though the data was interpreted with a slightly bent lens - discussed above. cdc.gov/mmwr/volumes/6…
16/30
Here are a few tips on interpreting Rapid Ag Test studies
a) Define the goal. If goal is screening contagiousness, then study should put any rapid Ag tests in context of virus culturability OR attempt to measure Rapid Ag test sensitivity stratified on viral RNA load
17/30
b) Virus Culture +ve does not necessarily mean someone is infectious.
Rather, it should be considered IMIO as a minimum bar to entry that someone might be.
If not culture +ve, then from a public health lens, the person is most likely NOT a major public health threat
18/30
c) Yes, some virus culture systems are more sensitive than others. Of course. But most will do fine to get at this broad metric of whether to consider a sample to have enough live virus to consider likely contagious and a public health threat.
19/30
d) If evaluating against PCR Ct values - do NOT assume consistent Cts across labs.
Some can be wildly different from next!
Though much discussion about this - it is oddly frequently ignored when assessing Rapid Ag tests.
20/30
For ex, many studies have found a Ct value of ~30 generally reflects the edge of culturability
Thus Ct 30 is often used as useful Ct cutoff for rapid Ag tests to shoot for
This is OK as a guide, but can be way off
This MMWR Study is a decent example of Ct 30 cutoff
21/30
If the PCR test being used to validate rapid test is calibrated with a lower Ct value (for whatever reason) this can make a rapid Ag test look much worse than it is.
I believe a real world example is currently sowing confusion in Liverpool, UK
22/30
In most studies that defined Ct ~30 as useful target for culturability/Rapid Ag tests, median Ct values of Asymptomatics is usually ~28-31:
Here is a mishmash of Studies showing Asymptomatic Cts - note medians are all around 30
23/30
In these studies 👆, rapid Ag test worked well up to Ct of ~30, or even better.
This is important b/c a very public study in Liverpool is showing outlier results where rapid Ag test looks like it is performing poorly... but I think the Ct distribution may be at play.
24/30
This study in Liverpool, UK is finding that Rapid Ag tests are performing well only up to a Ct value of about 22.
This is way different than other assessments of this same test - which have shown it works to Ct ~30, as expected.
However...
25/30
Inspection of Ct value distributions in Liverpool suggest shift in PCR Ct values:
The median Ct of Asymptomatic screening is a HUGE OUTLIER w median Ct of only ~21!
This is Exceptionally LOW for random screen of Asymptomatics - as shown in the figure a few tweets up.
26/30
The Ct result is either from a very rare chance of finding most asymptomatic people right at the peak of their infectivity (unlikely given the narrow time frame for this)
OR
More reasonably, the PCR lab may have a readout shifted down by about ~5-10 Cts.
27/30
There is other evidence for this.
The lab in the study claims a Ct value of ~30 equals ~100 viral RNA particles/mL
In MOST studies/labs, a Ct value ~100 RNA particles/mL is usually a Ct value of ~40.
Thus, in the Liverpool study, it is likely that the rapid Ag test is performing as we expect, Just that the PCR Ct values are shifted down from what we're used to seeing.
The study SHOULD evaluate vs culture to know for sure.
29/30
To CONCLUDE - we have to be very very careful when evaluating Rapid Antigen Tests.
We must DEFINE the purpose of the test. Determine the best comparison test for evaluation based on that definition, and only then report out how well the test is working.
30/31
Anything short of that ends up running into major problems with these tests.
This paper here is one of the best papers in terms of methods to evaluate rapid tests. IMO.
This 🧵 is on SPECIFICITY or the issues of False POSITIVES and rapid antigen tests.
Many people are concerned that these fast, inexpensive tests cause too many false positives and will overload PCR labs...
1/x
Rapid antigen tests can have 98%-99.9% specificity meaning between 0.1% and 2% of tests run might be falsely positive.
If prevalence is low, even a 99.9% specificity could mean many of the positive tests are falsely positive.
But w rapid tests, there are rapid solutions!
2/x
Many ppl instinctively worry that a false positive will mean an erroneous 10 day isolation and that huge numbers of people are going to require laboratory based PCR confirmation tests and this will overload the system.
But, Unlike antibiotics, the comparison has to consider even greater “only partial immunity” among those who have had no vaccine by the time they get infected.
1/x
@apoorva_nyc@TakeWeightOffMD The immune response is going to develop whether you’ve been vaccinated or not. If you’ve had no vaccine, then there is going to be much more “only partial immunity” that the virus gets to play around with and “test out”
2/x
@apoorva_nyc@TakeWeightOffMD We have to very careful to not forget what the baseline is here. W antibiotics, the Bacteria is only exposed to a partial dose if youre on antibiotics. With immunity, the virus is exposed to a partial dose whenever you’re not already protected while immunity builds up.
3/x
If testing Asymptomatics randomly (vs. repeatedly) - they are MOST likely to be found post-infectious -> EXPECT Ag to be -ve MOST of time someone is PCR +ve
The very paper @CDCgov links to that concludes rapid Ag tests do not perform well in Asymptomatics literally shows 100% sensitivity for culture +ve samples in Asymptomatics
Massive failure to not emphasize this for asymptomatic screening.
Rapid paper strip tests *could* be in everyone’s home today to curb spread immediately
Write to your congress ppl and demand they be a priority
1/
We make it easy for you to do this and have collected signatures from leading scientists requesting congress act on these - Set aside funds that amount to <1% of the most recent stimulus bill to get these tests to everyone, quickly and for months.
FDA / others think the populous is not capable of having simple tests at home & making responsible decisions
This is insane - plus we have expensive over the counter tests that require much technology - so I guess FDA feels the wealthy can use their own data but poor cannot. BS!
Many scientists have been frustrated that UK extended time between vaccine doses to ~12 weeks - in effort to get as many people as possible at least a single dose.
This makes sense for optimizing public health. But for optimizing individual protection it is controversial.
2/x
One scientist in the article said:
“I wouldn't want to be sitting around for 12 weeks waiting for the second dose with the partially protective vaccine,”
Under normal optimal circumstances, this opinion might be the right opinion, but In midst of a pandemic, it is faulty..
3/x
Importantly: UK is leading the way in taking a bold public health approach (vs individual health) to getting the population vaccinated - Prioritizing distribution of 1 dose & delaying dose 2 up to 12 weeks.
This bold move is going to cause ppl to scrutinize the decision. But in this pandemic, too few governments have acted swiftly to limit spread - bc quick action sometimes means imperfect data.
Here, robust data isn’t likely available for a 12 week delay for dose 2
But...
2/x
This was a good decision that
a) need not be permanent and suggests the UKG is willing to think with agility here and
b) likely will be the better overall public health approach rather than letting doses sit in freezers while others die and
3/x